145 related articles for article (PubMed ID: 27018332)
1. Studies on the in vitro and in vivo degradation behavior of amino acid derivative-based organogels.
Li Z; Cao J; Hu B; Li H; Liu H; Han F; Liu Z; Tong C; Li S
Drug Dev Ind Pharm; 2016 Nov; 42(11):1732-41. PubMed ID: 27018332
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled drug delivery system based on low-molecular-weight bis-amide organogelator: synthesis, properties and in vivo evaluation.
Li Z; Cao J; Li H; Liu H; Han F; Liu Z; Tong C; Li S
Drug Deliv; 2016 Oct; 23(8):3168-3178. PubMed ID: 26912188
[TBL] [Abstract][Full Text] [Related]
3. Degradation of glutamate-based organogels for biodegradable implants: In vitro study and in vivo observation.
Hu B; Wang W; Wang Y; Yang Y; Xu L; Li S
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():80-90. PubMed ID: 29025677
[TBL] [Abstract][Full Text] [Related]
4. Organogels based on amino acid derivatives and their optimization for drug release using response surface methodology.
Hu B; Yan H; Sun Y; Chen X; Sun Y; Li S; Jing Y; Li H
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):266-275. PubMed ID: 31851842
[TBL] [Abstract][Full Text] [Related]
5. Systematic modifications of amino acid-based organogelators for the investigation of structure-property correlations in drug delivery system.
Hu B; Sun W; Li H; Sui H; Li S
Int J Pharm; 2018 Aug; 547(1-2):637-647. PubMed ID: 29933060
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of 12-HSA-based organogels as injectable implants for the controlled delivery of hydrophilic and lipophilic therapeutic agents.
Esposito CL; Tardif V; Sarrazin M; Kirilov P; Roullin VG
Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():110999. PubMed ID: 32993979
[TBL] [Abstract][Full Text] [Related]
7. Combined effect of shearing and cooling rate on the rheology of organogels developed by selected gelators.
De la Peña-Gil A; Álvarez-Mitre FM; González-Chávez MM; Charó-Alonso MA; Toro-Vazquez JF
Food Res Int; 2017 Mar; 93():52-65. PubMed ID: 28290280
[TBL] [Abstract][Full Text] [Related]
8. Parenteral thermo-sensitive organogel for schizophrenia therapy, in vitro and in vivo evaluation.
Wang D; Zhao J; Liu X; Sun F; Zhou Y; Teng L; Li Y
Eur J Pharm Sci; 2014 Aug; 60():40-8. PubMed ID: 24815944
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
Jhawat V; Gupta S; Saini V
Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
[TBL] [Abstract][Full Text] [Related]
10. Characterization of organogel as a novel oral controlled release formulation for lipophilic compounds.
Iwanaga K; Sumizawa T; Miyazaki M; Kakemi M
Int J Pharm; 2010 Mar; 388(1-2):123-8. PubMed ID: 20045041
[TBL] [Abstract][Full Text] [Related]
11. Nanoengineering of a biocompatible organogel by thermal processing.
Li JL; Wang RY; Liu XY; Pan HH
J Phys Chem B; 2009 Apr; 113(15):5011-5. PubMed ID: 19309102
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing the erosion rate and the drug release kinetics from organogels designed as matrices for oral controlled release of a hydrophobic drug.
Pereira Camelo SR; Franceschi S; Perez E; Girod Fullana S; Ré MI
Drug Dev Ind Pharm; 2016; 42(6):985-97. PubMed ID: 26548427
[TBL] [Abstract][Full Text] [Related]
13. Application of Solvent Parameters for Predicting Organogel Formation.
Hu B; Sun W; Yang B; Li H; Zhou L; Li S
AAPS PharmSciTech; 2018 Jul; 19(5):2288-2300. PubMed ID: 29845502
[TBL] [Abstract][Full Text] [Related]
14. A novel chiral separation material: polymerized organogel formed by chiral gelators for the separation of D- and L-phenylalanine.
Fu X; Yang Y; Wang N; Wang H; Yang Y
J Mol Recognit; 2007; 20(4):238-44. PubMed ID: 17624913
[TBL] [Abstract][Full Text] [Related]
15. Lipase is essential for the study of in vitro release kinetics from organogels.
Dufresne MH; Marouf E; Kränzlin Y; Gauthier MA; Leroux JC
Mol Pharm; 2012 Jun; 9(6):1803-11. PubMed ID: 22510056
[TBL] [Abstract][Full Text] [Related]
16. Effect of organogel components on in vitro nasal delivery of propranolol hydrochloride.
Pisal S; Shelke V; Mahadik K; Kadam S
AAPS PharmSciTech; 2004 Sep; 5(4):e63. PubMed ID: 15760060
[TBL] [Abstract][Full Text] [Related]
17. Improved initial burst of estradiol organogel as long-term in situ drug delivery implant: formulation, in vitro and in vivo characterization.
Yang Y; Xu L; Gao Y; Wang Q; Che X; Li S
Drug Dev Ind Pharm; 2012 May; 38(5):550-6. PubMed ID: 22420863
[TBL] [Abstract][Full Text] [Related]
18. Chiral bis(amino acid)- and bis(amino alcohol)-oxalamide gelators. Gelation properties, self-assembly motifs and chirality effects.
Frkanec L; Zinić M
Chem Commun (Camb); 2010 Jan; 46(4):522-37. PubMed ID: 20062853
[TBL] [Abstract][Full Text] [Related]
19. Preparation of organogel with tea polyphenols complex for enhancing the antioxidation properties of edible oil.
Shi R; Zhang Q; Vriesekoop F; Yuan Q; Liang H
J Agric Food Chem; 2014 Aug; 62(33):8379-84. PubMed ID: 25089366
[TBL] [Abstract][Full Text] [Related]
20. An additional fluorenylmethoxycarbonyl (Fmoc) moiety in di-Fmoc-functionalized L-lysine induces pH-controlled ambidextrous gelation with significant advantages.
Reddy SM; Shanmugam G; Duraipandy N; Kiran MS; Mandal AB
Soft Matter; 2015 Nov; 11(41):8126-40. PubMed ID: 26338226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
